(Q36158047)

12 August 2017

1 reference

title

Effect of aldosterone and MR blockade on the brain and the kidney (English)

1 reference

12 August 2017

Charles T Stier

1

1 reference

12 August 2017

Ricardo Rocha

series ordinal

2

1 reference

12 August 2017

Praveen N Chander

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

1 January 2005

1 reference

12 August 2017

published in

Heart Failure Reviews

1 reference

12 August 2017

volume

10

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

53-62

1 reference

Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2349-X

Complete prevention of cerebral accidents in malignant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2349-X

Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2349-X

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2349-X

The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2349-X

Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-005-2349-X

Essential hypertension: renin and aldosterone, heart attack and stroke.

21 January 2018

1 reference

12 December 2020

Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats

1 reference

12 December 2020

Albuminuria in untreated patients with primary aldosteronism or essential hypertension

1 reference

12 December 2020

Potassium's cardiovascular protective mechanisms

1 reference

12 December 2020

Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma

1 reference

12 December 2020

Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.

1 reference

12 December 2020

Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet.

1 reference

12 December 2020

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

1 reference

12 December 2020

Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride.

1 reference

12 December 2020

Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease

1 reference

12 December 2020

Transforming growth factor-beta1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt

1 reference

12 December 2020

Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure

1 reference

12 December 2020

Potential importance of glomerular citrate synthase activity in remnant nephropathy

1 reference

12 December 2020

Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model

1 reference

12 December 2020

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

1 reference

12 December 2020

Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone.

1 reference

12 December 2020

Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension

1 reference

12 December 2020

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

1 reference

12 December 2020

Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron

1 reference

12 December 2020

Effect of aldosterone on renal transforming growth factor-beta

1 reference

12 December 2020

Role of aldosterone in the remnant kidney model in the rat.

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Pathophysiological effects of aldosterone in cardiovascular tissues

1 reference

12 December 2020

Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease

1 reference

12 December 2020

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

1 reference

12 December 2020

Cardiovascular complications in patients with primary aldosteronism

1 reference

12 December 2020

Resistance to remnant nephropathy in the Wistar-Furth rat.

1 reference

12 December 2020

Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent

1 reference

12 December 2020

Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.

1 reference

12 December 2020

Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect

1 reference

12 December 2020

Aldosterone in the development and progression of renal injury

1 reference

12 December 2020

Determinants of cardiac fibrosis in experimental hypermineralocorticoid states

1 reference

12 December 2020

Aldosterone: a mediator of myocardial necrosis and renal arteriopathy

1 reference

12 December 2020

Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level

1 reference

12 December 2020

Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism

1 reference

12 December 2020

Aldosterone as a mediator in cardiovascular injury

1 reference

12 December 2020

Influence of adrenalectomy and steroid replacement on heart citrate synthase levels

1 reference

12 December 2020

Amiloride reduces stroke and renalinjury in stroke-prone hypertensive rats

1 reference

12 December 2020

Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury

1 reference

12 December 2020

10.1007/S10741-005-2349-X

Identifiers

DOI

1 reference

12 August 2017

1 reference